Rankings
▼
Calendar
SRPT
Sarepta Therapeutics, Inc.
$2B
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$38M
Operating Income
-$60M
Net Income
-$60M
EPS (Diluted)
$-1.31
Cash Flow
Operating Cash Flow
-$61M
Free Cash Flow
-$62M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$213M
Total Liabilities
$74M
Stockholders' Equity
$139M
Cash & Equivalents
$38M
← FY 2016
All Quarters
Q2 2016 →
SRPT Q1 2016 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena